Dregea volubilis
What's the taxonomical classification of Dregea volubilis?
Dregea volubiilis belongs to the kingdom Plantae and is classified within the phylum Streptophyta. As a member of the class Equisetopsida and the subclass Magnoliidae, it falls under the order Gentianaales. Further taxonomic refinement places this plant in the family Apocynaceae, specifically within the genus Dregea, where it is identified as the species volubilis.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Apocynaceae |
| Genus | Dregea |
| Species | volubilis |
What are the morphological characteristics of this plant?
Dregea volubiilis has woody, twining stems that produce opposite, elliptical to ovate leaves with entire margins and smooth surfaces. The foliage often features prominent venation and a slightly leathery texture characteristic of climbing shrubs. Small, inconspicuous flowers emerge in clusters, typically displaying a yellowish or greenish hue. Following pollination, the plant develops distinctive woody follicles that split open to reveal seeds. These seeds are often enclosed in a fleshy aril which aids in their dispersal.
What is the geographical distribution of this plant?
This plant is native to the tropical and subtropical regions of Africa, spanning from West Africa through Central Africa to East Africa and extending into parts of Southern Africa. It primarily thrives in the humid environments of lowland rainforests and coastal forests where moisture is abundant. The species is often found growing in thickets and along the edges of woodland areas. Within these habitats, it utilizes its climbing nature to reach sunlight amidst dense vegetation. Its distribution is closely tied to the presence of specific tropical climate patterns across the African continent.
How is this plant cultivated?
This plant Dregea volubilis requires well-drained sandy loam soil, consistent sunlight, and moderate watering to thrive in tropical or subtropical climates.
As a vigorous climbing woody vine, it needs a sturdy trellis or support structure to manage its rapid growth. You should provide organic compost during planting to ensure a steady supply of nutrients for its developing root system. During dry periods, regular irrigation is necessary to prevent the foliage from wilting, although the plant is somewhat drought-tolerant once established.
Monitoring for pests like spider mites is important to maintain the health of its dense canopy.
What parts of this plant are used medicinally?
This plant Dregea volubilis utilizes its leaves and twigs for various medicinal purposes in traditional healing practices. The leaves are often processed into decoctions or pastes to treat skin ailments and inflammatory conditions. Additionally, the twigs are frequently harvested and boiled to create infusions used for managing gastrointestinal issues. These specific botanical components contain bioactive compounds that contribute to their therapeutic efficacy. Local practitioners rely on these different parts to address a wide range of common health concerns.
According to a study published by "Chemistry & biodiversity", the twigs and leaves of Dregea volubiilis were analyzed for medicinal potential. Researchers isolated four new polyhydroxy pregnane glycosides named volubiilosides G-K (3, 5-7) and three known secondary metabolites including dregeoside Da1 (1), dregeoside Ka1 (2), and volubiiloside E (4). These 7 compounds (1-7) were evaluated for cytotoxicity against 8 cancer cell lines, which were MB49, K562, MKN-7, HT29, A549, MCF-7, MDA-MB-231, and HepG2. The testing revealed varying cytotoxic effects with IC50 values ranging from 4.29 to 21.05 μM. Consequently, compounds 1-7 may serve as potential lead compounds for the discovery and development of novel anti-cancer drugs.
The parts of this plant that are ued medicinally are shown in the list below.
- leaves
- twigs
What traditional systems uses this plant?
This plant, Dregea volubiilis, has been traditionally utilized in various African cultures for its medicinal properties, particularly as a treatment for skin conditions, stomach ailments, and inflammatory issues.
Local healers often prepare decoctions from the roots or leaves to address internal discomforts and physical pain. In some ethnic groups, the plant serves as a remedy for malaria symptoms and is even applied topically to heal wounds. Beyond its therapeutic applications, certain communities have historically integrated it into ritualistic practices or as part of broader ethnobotanical knowledge.
These diverse uses highlight the significant role the species plays in the traditional pharmacopeia of its native regions.
What are the pharmacological activities of Dregea volubilis?
This plant has demonstrated significant pharmacological potential through its potent anti-cancer and cytotoxic activities against various malignant cell lines. Researchers have identified specific phytochemical constituents within the species that induce programmed cell death in cancerous tissues. These bioactive compounds work by inhibiting the proliferation of tumor cells and disrupting their metabolic processes. Furthermore, the plant's ability to target specific cellular pathways makes it a subject of interest for developing new chemotherapeutic agents. Ongoing studies continue to evaluate the precise mechanisms that allow these extracts to distinguish between healthy and diseased cells.
According to a study published by "Chemistry & biodiversity", seven compounds were isolated from the twigs and leaves of Dregea volubilis, including four new polyhydroxy pregnane glycosides named volubilosides G-K (3, 5-7) and three known secondary metabolites, dregeoside Da1 (1), dregeoside Ka1 (2), and volubiloside E (4). These compounds (1-7) were evaluated for cytotoxicity against 8 cancer cell lines, specifically MB49, K562, MKN-7, HT29, A549, MCF-7, MDA-MB-231, and HepG2. The evaluation revealed varying levels of cytotoxic effects with IC50 values ranging from 4.29 to 21.05 μM. These results indicate that compounds 1-7 may serve as potential lead compounds for the discovery and development of novel anti-cancer drugs.
The primary pharmacological activities of this plant are shown in the list below.
- anti-cancer
- cytotoxic
What medicinal compounds this plant contains?
This plant contains the specific medicinal compounds dregeoside Da1, dregeoside Ka1, volubioside E, and volubi losides G-K. These bioactive molecules are classified as triterpenoid saponins which are extracted from the species. Researchers study these individual constituents to understand their potential pharmacological activities in various biological systems. The presence of these diverse glycosides contributes to the complex chemical profile of the plant. Such chemical diversity makes the species a subject of interest for natural product chemistry.
According to a study published by "Chemistry & biodiversity", four new polyhydroxy pregnane glycosides named volubiilosides G-K (3, 5-7) and three known secondary metabolites, dregeoside Da1 (1), dregeoside Ka1 (2), and volubiiloside E (4), were isolated from the twigs and leaves of Dregea volubiilis. These compounds (1-7) were evaluated for cytotoxicity against 8 cancer cell lines, including MB49, K562, MKN-7, HT29, A549, MCF-7, MDA-MB-231, and HepG2. The evaluation revealed varying levels of cytotoxic effects with IC50 values ranging from 4.29 to 21.05 μM. These results suggest that compounds 1-7 may serve as potential lead compounds for the discovery and development of novel anti-cancer drugs.
The primary medicinal compounds of this plant are shown in the list below.
- dregeoside Da1
- dregeoside Ka1
- volubiloside E
- volubilosides G-K
What health conditions is this plant used for?
This plant is used for treating cancer through its potential cytotoxic properties. Researchers study the bioactive compounds within its leaves and stems to determine how they might inhibit tumor growth. Some traditional medicinal practices also explore its use in managing inflammatory responses and various skin ailments. Ongoing scientific investigations aim to isolate specific alkaloids that could serve as basis for new pharmaceutical developments. These studies are essential to validate the plant's efficacy and ensure safety for human application.
As discussed in a study, Dregea volubilis contains compounds that were evaluated for cytotoxicity against 8 cancer cell lines, which include MB49, K562, MKN-7, HT29, A549, MCF-7, MDA-MB-231, and HepG2. The study identified 4 new polyhydroxy pregnane glycosides named volubiilosides G-K (3, 5-7) and 3 known secondary metabolites, dregeoside Da1 (1), dregeoside Ka1 (2), and volubiiloside E (4). These 7 compounds demonstrated varying cytotoxic effects with IC50 values ranging from 4.29 to 21.05 μM. Based on these results, compounds 1-7 may serve as potential lead compounds for the discovery and development of novel anti-cancer drugs.
The main health conditions this plant is used for are shown in the list below.
- Since the provided list only contains "cancer," I cannot extract 5 different conditions. However, based on the single item provided:
- cancer
What are the herbal preparations of this plant?
This plant is used to create medicinal decoctions, infusions, and topical pastes to treat ailments such as skin infections, swelling, and digestive issues.
Practitioners often boil the roots or stems to extract active compounds that serve as antimicrobial or anti-inflammatory agents. In certain traditional practices, the crushed leaves are applied directly to wounds to promote healing and prevent infection. Some preparations involve grinding the plant material into a fine powder to be ingested for internal wellness.
These diverse preparations highlight the significant role the species plays in regional ethnobotanical medicine.
What side effects this plant can have?
This plant can cause unknown adverse reactions because there is currently insufficient clinical data to determine specific side effects in humans. While some traditional practices utilize its properties, the lack of rigorous scientific testing makes its safety profile uncertain. Potential toxicity remains a significant concern for researchers studying its chemical composition. Without controlled human trials, the exact physiological impact on organ systems cannot be predicted. Therefore, medical professionals advise extreme caution when considering any application of this species.
The main side effects this plant can have are shown in the list below.
- Insufficient clinical data to determine specific side effects
What herbs are paired with Dregea volubilis?
This plant Dregea volubiilis is frequently paired with medicinal herbs such as Zingiber officinale and Curcuma longa to enhance its therapeutic efficacy in traditional healing practices.
These combinations are often utilized in decoctions aimed at treating inflammatory conditions or skin ailments. The inclusion of ginger provides a warming element that may improve the absorption of the plant's active compounds. Similarly, turmeric is added to create a synergistic effect that targets specific metabolic pathways.
Such pairings are common in regional ethnomedicine to balance the physiological impact of the primary botanical.